US20020010508A1 - Layered endovascular graft - Google Patents

Layered endovascular graft Download PDF

Info

Publication number
US20020010508A1
US20020010508A1 US09/970,576 US97057601A US2002010508A1 US 20020010508 A1 US20020010508 A1 US 20020010508A1 US 97057601 A US97057601 A US 97057601A US 2002010508 A1 US2002010508 A1 US 2002010508A1
Authority
US
United States
Prior art keywords
thin wall
graft
wall graft
members
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/970,576
Inventor
Michael Chobotov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TriVascular Inc
Endologix LLC
Original Assignee
TriVascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TriVascular Inc filed Critical TriVascular Inc
Priority to US09/970,576 priority Critical patent/US20020010508A1/en
Publication of US20020010508A1 publication Critical patent/US20020010508A1/en
Assigned to TRIVASCULAR, INC. reassignment TRIVASCULAR, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHOBOTOV, MICHAEL V.
Priority to US10/803,153 priority patent/US20040220664A1/en
Assigned to DEERFIELD ELGX REVOLVER, LLC, AS AGENT reassignment DEERFIELD ELGX REVOLVER, LLC, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ENDOLOGIX, INC., NELLIX, INC., TRIVASCULAR, INC.
Assigned to DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT reassignment DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ENDOLOGIX, INC., NELLIX, INC., TRIVASCULAR, INC.
Assigned to DEERFIELD PRIVATE DESIGN FUND IV, L.P. reassignment DEERFIELD PRIVATE DESIGN FUND IV, L.P. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ENDOLOGIX LLC (F/K/A ENDOLOGIX, INC.), NELLIX, INC., TRIVASCULAR CANADA, LLC, TRIVASCULAR TECHNOLOGIES, INC., TRIVASCULAR, INC.
Assigned to ENDOLOGIX LLC reassignment ENDOLOGIX LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ENDOLOGIX, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0033Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • A61F2250/0007Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting length
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular
    • A61F2250/0063Nested prosthetic parts

Definitions

  • the present invention relates to a system and method for the treatment of disorders of the vasculature. More specifically, a system and method for treatment of thoracic or abdominal aortic aneurysm and the like, which is a condition manifested by expansion and weakening of the aorta. Such conditions require intervention due to the severity of the sequelae, which frequently is death.
  • Prior methods of treating aneurysms have consisted of invasive surgical methods with graft placement within the affected vessel as a reinforcing member of the artery.
  • the grafts and the delivery catheters used to deliver the grafts are relatively large in profile, often up to 24 French and greater, and stiff in bending.
  • the large profile and bending stiffness makes delivery through the irregular and tortuous arteries of diseased vessels difficult and risky.
  • the iliac arteries are often too narrow or irregular for the passage of a percutaneous device.
  • current devices are particularly challenged to reach the deployment sizes and diameters required for treatment of lesions in the aorto and aorto-iliac regions. Because of this, non-invasive percutaneous graft delivery for treatment of aortic aneurysm is not available to many patients who would benefit from it.
  • the present invention is directed generally to a system and method for treatment of a body lumen or passageway within a patient's body. More specifically, the invention is directed to an endovascular graft for treatment of weakened or diseased blood vessels which has at least two thin wall graft members which are configured to be nested or layered over each other in a deployed state. By layering a plurality of thin wall graft members, each layer can be delivered by a smaller more flexible catheter delivery system than is used for conventional single graft systems.
  • the system of the present invention may delivered intraoperatively, but is preferably delivered percutaneously.
  • One embodiment of the invention is a graft for supporting a preselected length of a patient's body lumen or passageway that is created from at least two separate thin wall graft members.
  • the thin wall graft members are configured to be nested or layered when deployed in an overlapping fashion that combines the strength of the members in the areas or portions that are overlapped.
  • One advantage of such a system and method is that each individual thin wall graft member can be constructed with less bulk and material mass than would be required for a single component graft of similar strength. This allows each separate thin wall graft member to have a smaller more flexible profile in a compressed or constricted state and be deliverable through a smaller and more flexible delivery system which improves access to preselected lengths of compromised or diseased body lumens.
  • the graft can be configured so that no single component or thin wall graft member has sufficient mechanical strength to provide a desired amount of support for a preselected length of a patient's body lumen.
  • the thin wall graft members can be designed so that a desired amount of mechanical strength can be achieved with two or more layers or overlapped portions of the graft. In some indications, it may be desirable to have three, four, five or more layers required to achieve the desired amount of mechanical strength and support for the patient's body lumen. While a graft requiring more layers for sufficient strength may be more time consuming to deploy, each thin wall graft member or component can be made correspondingly thinner and with a lower more flexible profile in a constrained or compressed state. This allows a correspondingly smaller and more flexible catheter delivery system to be used to access the preselected length of body lumen to be treated.
  • the inner-most and lastly deployed thin wall graft member be of a longitudinal length greater than the previously deployed thin wall graft members, individually, or cumulatively as deployed.
  • the lastly deployed thin wall graft member can extend longitudinally from one or both ends of the graft and provide a smooth transition into the graft for blood flow and a smooth inner surface for the graft in its final deployed state.
  • each thin wall graft member that provides a portion of the requisite desired strength can be anchored with appropriate anchoring mechanisms in tissue that is healthy or of sufficient integrity to be capable of supporting the anchoring mechanisms.
  • Each thin wall graft member is typically equipped with at least one anchoring mechanism at each end to prevent the thin wall graft member from being displaced from the deployment site and to facilitate sealing of the graft member against an inside surface of the patient's body lumen or vessel.
  • thin wall graft members are linked to allow relative longitudinal movement or displacement of the members.
  • each thin wall graft member is connected to an adjacent member in a telescopic manner. This allows the graft members to be extended longitudinally so that only one thickness of graft member need be compressed or constrained for loading of the graft into a delivery catheter system, except for the short lengths of overlapped portion where the ends of the thin wall graft members are joined. This provides some of the advantages of the separate individually deliverable thin wall graft members while maintaining an integral structure.
  • the telescoping graft can be deployed by positioning each thin wall graft member within an adjacent thin wall graft member after exiting the distal end of the delivery catheter system.
  • the graft is then expanded as a whole at a preselected site within the patient's body lumen.
  • the graft may be deployed one thin wall graft member at a time, with each graft member deployed and expanded radially in a desired position as it exits the delivery catheter system.
  • FIG. 1 shows an elevational view of an endovascular graft having features of the invention.
  • FIG. 2 shows a transverse cross section of the endovascular graft of FIG. 1 taken at lines 2 - 2 of FIG. 1.
  • FIG. 3 shows a longitudinal cross sectional view of the endovascular graft of FIG. 1 taken at lines 3 - 3 of FIG. 1.
  • FIG. 4 is an elevational view of a catheter delivery system suitable for delivery of a graft having features of the invention.
  • FIG. 5 is a transverse cross sectional view of the catheter delivery system of FIG. 4 taken at lines 5 - 5 in FIG. 4.
  • FIG. 6 is a longitudinal cross sectional view of a graft having features of the invention deployed in a patient's body lumen.
  • FIG. 7 is an elevational view in section of a bifurcated embodiment of a graft having features of the invention.
  • FIG. 8 is a transverse cross sectional view of the endovascular graft of FIG. 7 taken at lines 8 - 8 of FIG. 7.
  • An endovascular graft having features of the invention allows for minimally invasive surgical repair or treatment of aneurysms, arteriovenous fistula, and other vascular diseases and injuries of the type found in the aorta and aorto-iliac bifurcation of the human anatomy.
  • the graft can be delivered via a catheter delivery system to the site of the disease or injury, where it is assembled and deployed to provide an internal bypass conduit for blood flow through the diseased, injured or otherwise compromised artery. Isolation of the lesion is thereby achieved, eliminating the risk associated with loss of flow path integrity e.g. rupture of an aneurysm.
  • the graft is typically made of a plurality of tubular prostheses or thin wall graft members, each of which is constructed using a small support structure and a very thin graft material such as DacronTM or ePTFE.
  • Each component prosthesis or thin wall graft member is nested, laminated or layered in situ to form a completed structurally sound stent-graft.
  • Each component is delivered sequentially, overlapping partially or completely the component or components previously deployed.
  • an initial bifurcated laminate, component or thin wall graft member can be positioned and followed by multiple tubular thin wall graft members into each leg of the original bifurcated graft member.
  • each component or graft member may be of bifurcated construction and be sequentially laminated or deployed in place within a preselected portion of a patient's body lumen or vessel.
  • Progressive overlap of thin wall graft members can be used to traverse preselected portions of a patient's body lumen that have significant angulation so long as there are sufficient layers of thin wall graft member built up over the entire compromised preselected portion of the lumen.
  • this method can incorporate the use of thin wall graft members or components having a relatively short longitudinal length so as to decrease the tendency of each graft member to buckle or fold on itself as a result of conforming to the angulation.
  • the thin wall graft members can contain deformable wire at their proximal and distal ends to allow anchoring to the body lumen wall in locations proximal and distal the compromised or diseased portion of the body lumen.
  • the deformable wire portions or anchoring mechanisms can be used to secure the graft to the lumen wall of the patient, or to secure the thin wall graft members to each other.
  • the deformable wires can be self expanding from a constrained state or balloon expandable.
  • adjacent thin wall graft members can be secured to each other or the lumen wall with hooks or suitable polymer adhesives, such as cyanoacrylate compounds.
  • Size differences between the various graft members that make up a graft can be determined by specific materials, architectures and applications.
  • Each graft member can have radiopaque markers or materials to facilitate imaging of the graft members during delivery and deployment.
  • the number, size and shape of the thin wall graft members can be selected from a standard set or adjusted so as to allow tailoring of the final device shape to a patient's specific anatomy, and can be defined with the assistance of a flouroscopic imaging, spiral CT angiography or MRI.
  • each member will be smaller, more flexible, and have a lower profile than would a single element device typically used to treat the same body lumen. While each individual graft member may lack the necessary mechanical characteristics or properties of a completed graft or device, the aggregate assembly of all of the components in situ will achieve the required structural objectives. These objectives include strength, stiffness, and nonporosity necessary for device patentcy, hemodynamic sealing, and prevention of perigraft leakage. This approach will allow for improved percutaneous delivery through a delivery catheter system to preselected portions of a body lumen using smaller diameter delivery catheters than those typically used.
  • a nested or layered approach used for deploying tubular members can also be used for treatment of occlusive disease using stents and stent-grafts.
  • a series of concentric stents that converge concentrically into position for deployment can be used to achieve similar benefits of delivery flexibility and low profile.
  • the stent components would be extended linearly in telescopic fashion within a delivery catheter, with each successive component or stent member sized to fit inside the adjacent stent member or component.
  • FIG. 1 a thin wall graft member 10 is shown having a frame 11 , a first anchoring mechanism 12 , a second anchoring mechanism 13 , and a tubular membrane 14 disposed within and secured to the frame.
  • FIG. 2 shows a transverse cross section of the thin wall graft member 10 of FIG. 1 with the membrane 14 disposed within and secured to the frame 11 .
  • FIG. 3 is a longitudinal cross section of the thin wall graft member 10 of FIG. 1 with the membrane 14 disposed within the frame 11 and first anchoring mechanism 12 disposed at a first end 15 of the member and a second anchoring mechanism 13 disposed at a second end 16 of the member.
  • the graft can be configured so that no single component or thin wall graft member has sufficient mechanical strength to provide a desired amount of support for a preselected length of a patient's body lumen.
  • the thin wall graft members can be designed so that a desired amount of mechanical strength can be achieved with two or more layers or overlapped portions of the graft. In some indications, it may be desirable to have three, four, five or more layers required to achieve the desired amount of mechanical strength and support for the patient's body lumen.
  • the frame 11 is made from an expandable wire 17 , preferably a pseudoelastic alloy such as NiTi alloy, but can also be made from a high strength material such as stainless steel or Co—Cr—Ni alloys such as MP35N and the like.
  • the material of the frame has a diameter or transverse dimension of about 0.010 inches, but can be from about 0.005 to about 0.016 inches.
  • the first anchoring mechanism and second anchoring mechanism 13 are made of materials similar to those of the frame.
  • the anchoring mechanisms 12 and 13 are of NiTi alloy having a transverse dimension of about 0.01 inches, but can be from about 0.005 to about 0.016 inches in transverse dimension.
  • the thin wall graft member 10 is shown with a frame 11 , the graft member can be constructed without the frame and be supported by anchoring mechanisms 12 and 13 alone.
  • the membrane 14 is preferably made from DacronTM or ePTFE fabric but can be of any other suitable thin material that can impede the flow of blood or other bodily fluids. Additional suitable materials can include polyurethane, polyvinylchloride, PET, PEEK and the like. The thickness of the membrane 14 is about 0.004 inches, but can be from about 0.002 to about 0.008 inches.
  • the thin wall graft member 10 is generally longer than the compromised tissue or aneurysm of the patient's body lumen, and is about 6 to about 20 cm, preferably about 8 to about 12 cm.
  • the transverse dimension of the thin wall graft member is about 15 to about 40 mm, preferably about 20 to about 35 mm.
  • the maximum transverse dimension of the graft member 10 is as described above, the graft member can be expanded or self expanding to any size up to the maximum transverse dimension and engage a lumen wall in which the graft member is being deployed.
  • the graft member 10 will generally be sized to have a slightly larger maximum transverse dimension than the transverse dimension of the vessel or lumen within which it is to be deployed. This allows for the anchoring mechanisms 12 and 13 and frame 11 to engage the inside surface of the body lumen and be secured and at least partially sealed thereto.
  • the graft member 10 is compressible or constrainable to a smaller transverse dimension for loading into a delivery catheter system.
  • the smallest transverse dimension that the graft member 10 can be constrained to for loading and delivery into and out of a suitable delivery catheter is the minimum transverse dimension.
  • the minimum transverse dimension of the graft member 10 in a constrained state is about 4 mm, but can be up to about 6 mm.
  • the minimum transverse dimension of the graft member is about 2 to about 4 mm.
  • FIG. 4 is an elevational view of a delivery catheter 21 having a proximal end 22 , a distal end 23 , and a distal section 24 .
  • Luer connector 25 is disposed at the proximal end 22 of the delivery catheter.
  • the delivery catheter 21 is constructed using common guiding or delivery catheter methods and can be of a solid polymer material or optionally can have a mesh, coil or braid of a suitable high strength metal or fiber embedded therein.
  • FIG. 5 is a transverse cross sectional view of the delivery catheter 21 shown in FIG. 4 taken at lines 5 - 5 in FIG. 4 at the distal section 24 of the delivery catheter.
  • the delivery catheter 21 has a lumen 26 extending the length of the catheter which has an inner diameter of about 4 to about 5 mm.
  • the wall 27 of the distal section 24 has a thickness of about 0.01 inches, but can have a thickness of about 0.005 to about 0.05 inches.
  • the length of the delivery catheter 21 is about 20 to about 50 cm, but can be about 10 to about 150 cm.
  • the delivery catheter 21 preferably has a low friction surface inside the lumen to facilitate deployment of thin wall graft members.
  • the wall 27 of the delivery catheter 21 is shown as having a single polymer layer, but may be constructed of multiple concentric or eccentric layers, preferably with the inner-most layer being of a low friction polymer such as TFE or high density polypropylene.
  • Other suitable polymers for the delivery catheter 21 include polyurethane, polyvinylchloride, polyimide, polyamide and the like.
  • the delivery catheter 21 may also optionally have more than one lumen, including a lumen for passage of a guidewire or similar device.
  • FIG. 6 shows a graft 31 having features of the invention deployed within a preselected portion 32 of a patient's body lumen 33 .
  • the preselected portion 32 of the patient's body lumen 33 has a distended portion 34 that is representative of an aortic aneurysm or the like.
  • the body lumen 33 has a wall 35 that is engaged by the graft 31 .
  • a second or inner-most thin wall graft member 36 is disposed and deployed within a first thin wall graft member 37 .
  • a first end 38 of the second thin wall graft member 36 is extending longitudinally from a first end 41 of the first thin wall graft member 37 to provide a smooth transition for a flow of blood therethrough as indicated by arrow 39 .
  • Both the first and second thin wall graft members 36 and 37 completely span the preselected portion 32 of the patient's body lumen.
  • the first end 41 of the first thin wall graft member 37 and the first end 38 of the second thin wall graft member are secured to a healthy tissue portion 42 of the body lumen 33 .
  • a second end 43 of the first thin wall graft member 37 and a second end 44 of the second thin wall graft member 36 are also secured to a healthy tissue portion 42 of the body lumen.
  • the healthy tissue portion 42 of the patient's body lumen 33 is shown as having a constant diameter in FIG. 6, the term healthy tissue portion or is intended to mean any portion of a patient's body lumen or passageway that has sufficient strength or integrity to support an anchoring mechanism 12 and 13 of the type discussed herein above.
  • FIG. 7 is an elevational view of a bifurcated embodiment of a graft 50 having features of the invention shown in an expanded deployed state.
  • a second thin wall graft member 51 is disposed within a first thin wall graft member 52 .
  • the first thin wall graft member 51 and the second thin wall graft member 52 each have a bifurcated configuration and each have a construction similar to that of the of the thin wall graft of FIGS. 1 - 3 .
  • FIG. 8 is a transverse cross sectional view of the graft 50 of FIG. 7 taken at lines 8 - 8 of FIG. 7.
  • the first thin wall graft member 52 is bifurcated and has a frame 53 and a membrane 54 within the frame.
  • the second thin wall graft member 51 is disposed within the first thin wall graft member 52 and has a frame 55 and a membrane 56 within the frame.
  • the cross section of the first thin wall member 52 and second thin wall member 51 is shown as round, but is sufficiently flexible to assume a variety of shapes necessary to engage an inside surface of a body lumen, including irregularly shaped body lumens.
  • any suitable number of graft members could be used, so long as all portions of the graft 50 which span a preselected length of the patient's body lumen which is compromised have a sufficient number of graft member layers and structural strength to maintain a flow of blood therethrough and prevent leakage or failure of the patient's body lumen.
  • the thin wall graft members 51 and 52 of FIG. 7 are shown as complete bifurcated embodiments, however, they may optionally be formed from multiple overlapping thin wall graft members that are individually either partially bifurcated or not bifurcated at all.

Abstract

A endovascular graft having at least two thin wall graft members, with at least one of the thin wall graft members configured to be deployed within a lumen of another thin wall graft member. The thin wall graft members may be coupled or connected to each other so as to allow relative axial displacement of the sections, or they may be separate members that have dimensions and a configuration to allow coaxial deployment within inner lumens of each other. By having multiple thin wall graft member, the graft may be built up within a patient's vasculature in steps through a delivery catheter system that is smaller in profile and more flexible than a delivery catheter system configured to deliver a single component graft. The graft of the invention may be delivered percutaneously or intraoperatively.

Description

    RELATED APPLICATIONS
  • This application is a continuation-in-part of Provisional Application Ser. No. 60/066,301, filed Nov. 25, 1997. Priority is hereby claimed to Provisional Application Ser. No. 60/066,301, which also incorporated by reference in its entirety herein.[0001]
  • BACKGROUND OF THE INVENTION
  • The present invention relates to a system and method for the treatment of disorders of the vasculature. More specifically, a system and method for treatment of thoracic or abdominal aortic aneurysm and the like, which is a condition manifested by expansion and weakening of the aorta. Such conditions require intervention due to the severity of the sequelae, which frequently is death. Prior methods of treating aneurysms have consisted of invasive surgical methods with graft placement within the affected vessel as a reinforcing member of the artery. However, such a procedure requires a surgical cut down to access the vessel, which in turn can result in a catastrophic rupture of the aneurysm due to the decreased external pressure from the surrounding organs and tissues, which are moved during the procedure to gain access to the vessel. Accordingly, surgical procedures have a high mortality rate due to the possibility of the rupture discussed above in addition to other factors. Other factors can include poor physical condition of the patient due to blood loss, anuria, and low blood pressure associated with the aortic abdominal aneurysm. An example of a surgical procedure is described in a book entitled [0002] Surgical Treatment of Aortic Aneurysms by Denton A. Cooley, M.D., published in 1986 by W. B. Saunders Company.
  • Due to the inherent risks and complexities of surgical procedures, various attempts have been made in the development of alternative methods for deployment of grafts within aortic aneurysms. One such method is the noninvasive technique of percutaneous delivery by a catheter-based system. Such a method is described in Lawrence, Jr. et al. in “Percutaneous endovascular graft: experimental evaluation”, [0003] Radiology (May 1987). Lawrence described therein the use of a Gianturco stent as disclosed in U.S. Pat. No. 4,580,568. The stent is used to position a Dacron fabric graft within the vessel. The Dacron graft is compressed within the catheter and then deployed within the vessel to be treated. A similar procedure has also been described by Mirich et al. in “Percutaneously placed endovascular grafts for aortic aneurysms: feasibility study,” Radiology (March 1989). Mirich describes therein a self-expanding metallic structure covered by a nylon fabric, with said structure being anchored by barbs at the proximal and distal ends.
  • One of the primary deficiencies of the existing percutaneous devices and methods has been that the grafts and the delivery catheters used to deliver the grafts are relatively large in profile, often up to 24 French and greater, and stiff in bending. The large profile and bending stiffness makes delivery through the irregular and tortuous arteries of diseased vessels difficult and risky. In particular, the iliac arteries are often too narrow or irregular for the passage of a percutaneous device. In addition, current devices are particularly challenged to reach the deployment sizes and diameters required for treatment of lesions in the aorto and aorto-iliac regions. Because of this, non-invasive percutaneous graft delivery for treatment of aortic aneurysm is not available to many patients who would benefit from it. [0004]
  • While the above methods have shown some promise with regard to treating thoracic and abdominal aortic aneurysms with non-invasive methods, there remains a need for an endovascular graft system which can be deployed percutaneously in a small diameter flexible catheter system. The present invention satisfies these and other needs. [0005]
  • SUMMARY OF THE INVENTION
  • The present invention is directed generally to a system and method for treatment of a body lumen or passageway within a patient's body. More specifically, the invention is directed to an endovascular graft for treatment of weakened or diseased blood vessels which has at least two thin wall graft members which are configured to be nested or layered over each other in a deployed state. By layering a plurality of thin wall graft members, each layer can be delivered by a smaller more flexible catheter delivery system than is used for conventional single graft systems. The system of the present invention may delivered intraoperatively, but is preferably delivered percutaneously. [0006]
  • One embodiment of the invention is a graft for supporting a preselected length of a patient's body lumen or passageway that is created from at least two separate thin wall graft members. The thin wall graft members are configured to be nested or layered when deployed in an overlapping fashion that combines the strength of the members in the areas or portions that are overlapped. One advantage of such a system and method is that each individual thin wall graft member can be constructed with less bulk and material mass than would be required for a single component graft of similar strength. This allows each separate thin wall graft member to have a smaller more flexible profile in a compressed or constricted state and be deliverable through a smaller and more flexible delivery system which improves access to preselected lengths of compromised or diseased body lumens. [0007]
  • The graft can be configured so that no single component or thin wall graft member has sufficient mechanical strength to provide a desired amount of support for a preselected length of a patient's body lumen. The thin wall graft members can be designed so that a desired amount of mechanical strength can be achieved with two or more layers or overlapped portions of the graft. In some indications, it may be desirable to have three, four, five or more layers required to achieve the desired amount of mechanical strength and support for the patient's body lumen. While a graft requiring more layers for sufficient strength may be more time consuming to deploy, each thin wall graft member or component can be made correspondingly thinner and with a lower more flexible profile in a constrained or compressed state. This allows a correspondingly smaller and more flexible catheter delivery system to be used to access the preselected length of body lumen to be treated. [0008]
  • In some embodiments, it may be preferable to have the inner-most and lastly deployed thin wall graft member be of a longitudinal length greater than the previously deployed thin wall graft members, individually, or cumulatively as deployed. In this way, the lastly deployed thin wall graft member can extend longitudinally from one or both ends of the graft and provide a smooth transition into the graft for blood flow and a smooth inner surface for the graft in its final deployed state. [0009]
  • Generally it is desirable for the preselected length of a patient's body lumen which is compromised or requires treatment to be completely spanned by at least the number of thin wall graft members required to achieve a desired amount of mechanical strength and support. In this way, each thin wall graft member that provides a portion of the requisite desired strength can be anchored with appropriate anchoring mechanisms in tissue that is healthy or of sufficient integrity to be capable of supporting the anchoring mechanisms. Each thin wall graft member is typically equipped with at least one anchoring mechanism at each end to prevent the thin wall graft member from being displaced from the deployment site and to facilitate sealing of the graft member against an inside surface of the patient's body lumen or vessel. [0010]
  • In an alternative embodiment of a graft of the present invention, thin wall graft members are linked to allow relative longitudinal movement or displacement of the members. In a preferred embodiment, each thin wall graft member is connected to an adjacent member in a telescopic manner. This allows the graft members to be extended longitudinally so that only one thickness of graft member need be compressed or constrained for loading of the graft into a delivery catheter system, except for the short lengths of overlapped portion where the ends of the thin wall graft members are joined. This provides some of the advantages of the separate individually deliverable thin wall graft members while maintaining an integral structure. The telescoping graft can be deployed by positioning each thin wall graft member within an adjacent thin wall graft member after exiting the distal end of the delivery catheter system. The graft is then expanded as a whole at a preselected site within the patient's body lumen. Alternatively, the graft may be deployed one thin wall graft member at a time, with each graft member deployed and expanded radially in a desired position as it exits the delivery catheter system. [0011]
  • These and other advantages of the invention will become more apparent from the following detailed description of the invention when taken in conjunction with the accompanying exemplary drawings.[0012]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows an elevational view of an endovascular graft having features of the invention. [0013]
  • FIG. 2 shows a transverse cross section of the endovascular graft of FIG. 1 taken at lines [0014] 2-2 of FIG. 1.
  • FIG. 3 shows a longitudinal cross sectional view of the endovascular graft of FIG. 1 taken at lines [0015] 3-3 of FIG. 1.
  • FIG. 4 is an elevational view of a catheter delivery system suitable for delivery of a graft having features of the invention. [0016]
  • FIG. 5 is a transverse cross sectional view of the catheter delivery system of FIG. 4 taken at lines [0017] 5-5 in FIG. 4.
  • FIG. 6 is a longitudinal cross sectional view of a graft having features of the invention deployed in a patient's body lumen. [0018]
  • FIG. 7 is an elevational view in section of a bifurcated embodiment of a graft having features of the invention. [0019]
  • FIG. 8 is a transverse cross sectional view of the endovascular graft of FIG. 7 taken at lines [0020] 8-8 of FIG. 7.
  • DETAILED DESCRIPTION
  • An endovascular graft having features of the invention allows for minimally invasive surgical repair or treatment of aneurysms, arteriovenous fistula, and other vascular diseases and injuries of the type found in the aorta and aorto-iliac bifurcation of the human anatomy. The graft can be delivered via a catheter delivery system to the site of the disease or injury, where it is assembled and deployed to provide an internal bypass conduit for blood flow through the diseased, injured or otherwise compromised artery. Isolation of the lesion is thereby achieved, eliminating the risk associated with loss of flow path integrity e.g. rupture of an aneurysm. [0021]
  • The graft is typically made of a plurality of tubular prostheses or thin wall graft members, each of which is constructed using a small support structure and a very thin graft material such as Dacron™ or ePTFE. Each component prosthesis or thin wall graft member is nested, laminated or layered in situ to form a completed structurally sound stent-graft. Each component is delivered sequentially, overlapping partially or completely the component or components previously deployed. For bifurcated applications, an initial bifurcated laminate, component or thin wall graft member can be positioned and followed by multiple tubular thin wall graft members into each leg of the original bifurcated graft member. Alternatively, each component or graft member may be of bifurcated construction and be sequentially laminated or deployed in place within a preselected portion of a patient's body lumen or vessel. Progressive overlap of thin wall graft members can be used to traverse preselected portions of a patient's body lumen that have significant angulation so long as there are sufficient layers of thin wall graft member built up over the entire compromised preselected portion of the lumen. For body lumens with high angulation, this method can incorporate the use of thin wall graft members or components having a relatively short longitudinal length so as to decrease the tendency of each graft member to buckle or fold on itself as a result of conforming to the angulation. [0022]
  • The thin wall graft members can contain deformable wire at their proximal and distal ends to allow anchoring to the body lumen wall in locations proximal and distal the compromised or diseased portion of the body lumen. The deformable wire portions or anchoring mechanisms can be used to secure the graft to the lumen wall of the patient, or to secure the thin wall graft members to each other. The deformable wires can be self expanding from a constrained state or balloon expandable. In addition to the deformable wires, adjacent thin wall graft members can be secured to each other or the lumen wall with hooks or suitable polymer adhesives, such as cyanoacrylate compounds. Size differences between the various graft members that make up a graft can be determined by specific materials, architectures and applications. Each graft member can have radiopaque markers or materials to facilitate imaging of the graft members during delivery and deployment. The number, size and shape of the thin wall graft members can be selected from a standard set or adjusted so as to allow tailoring of the final device shape to a patient's specific anatomy, and can be defined with the assistance of a flouroscopic imaging, spiral CT angiography or MRI. [0023]
  • The nested or layered approach to deploying the thin wall graft members described herein will allow each member to be smaller, more flexible, and have a lower profile than would a single element device typically used to treat the same body lumen. While each individual graft member may lack the necessary mechanical characteristics or properties of a completed graft or device, the aggregate assembly of all of the components in situ will achieve the required structural objectives. These objectives include strength, stiffness, and nonporosity necessary for device patentcy, hemodynamic sealing, and prevention of perigraft leakage. This approach will allow for improved percutaneous delivery through a delivery catheter system to preselected portions of a body lumen using smaller diameter delivery catheters than those typically used. [0024]
  • A nested or layered approach used for deploying tubular members can also be used for treatment of occlusive disease using stents and stent-grafts. A series of concentric stents that converge concentrically into position for deployment can be used to achieve similar benefits of delivery flexibility and low profile. During delivery the stent components would be extended linearly in telescopic fashion within a delivery catheter, with each successive component or stent member sized to fit inside the adjacent stent member or component. Once the leading end of the series of components of stent members reaches a preselected lesion site within a patient's body lumen, the remaining stent members or components are moved into position for deployment and completion and consolidation of the device. [0025]
  • Referring to FIG. 1, a thin wall graft member [0026] 10 is shown having a frame 11, a first anchoring mechanism 12, a second anchoring mechanism 13, and a tubular membrane 14 disposed within and secured to the frame. FIG. 2 shows a transverse cross section of the thin wall graft member 10 of FIG. 1 with the membrane 14 disposed within and secured to the frame 11. FIG. 3 is a longitudinal cross section of the thin wall graft member 10 of FIG. 1 with the membrane 14 disposed within the frame 11 and first anchoring mechanism 12 disposed at a first end 15 of the member and a second anchoring mechanism 13 disposed at a second end 16 of the member.
  • The graft can be configured so that no single component or thin wall graft member has sufficient mechanical strength to provide a desired amount of support for a preselected length of a patient's body lumen. The thin wall graft members can be designed so that a desired amount of mechanical strength can be achieved with two or more layers or overlapped portions of the graft. In some indications, it may be desirable to have three, four, five or more layers required to achieve the desired amount of mechanical strength and support for the patient's body lumen. The frame [0027] 11 is made from an expandable wire 17, preferably a pseudoelastic alloy such as NiTi alloy, but can also be made from a high strength material such as stainless steel or Co—Cr—Ni alloys such as MP35N and the like.
  • The material of the frame has a diameter or transverse dimension of about 0.010 inches, but can be from about 0.005 to about 0.016 inches. The first anchoring mechanism and second anchoring mechanism [0028] 13 are made of materials similar to those of the frame. The anchoring mechanisms 12 and 13 are of NiTi alloy having a transverse dimension of about 0.01 inches, but can be from about 0.005 to about 0.016 inches in transverse dimension. Although the thin wall graft member 10 is shown with a frame 11, the graft member can be constructed without the frame and be supported by anchoring mechanisms 12 and 13 alone.
  • The membrane [0029] 14 is preferably made from Dacron™ or ePTFE fabric but can be of any other suitable thin material that can impede the flow of blood or other bodily fluids. Additional suitable materials can include polyurethane, polyvinylchloride, PET, PEEK and the like. The thickness of the membrane 14 is about 0.004 inches, but can be from about 0.002 to about 0.008 inches.
  • The thin wall graft member [0030] 10 is generally longer than the compromised tissue or aneurysm of the patient's body lumen, and is about 6 to about 20 cm, preferably about 8 to about 12 cm. The transverse dimension of the thin wall graft member is about 15 to about 40 mm, preferably about 20 to about 35 mm. Although the maximum transverse dimension of the graft member 10 is as described above, the graft member can be expanded or self expanding to any size up to the maximum transverse dimension and engage a lumen wall in which the graft member is being deployed. The graft member 10 will generally be sized to have a slightly larger maximum transverse dimension than the transverse dimension of the vessel or lumen within which it is to be deployed. This allows for the anchoring mechanisms 12 and 13 and frame 11 to engage the inside surface of the body lumen and be secured and at least partially sealed thereto.
  • The graft member [0031] 10 is compressible or constrainable to a smaller transverse dimension for loading into a delivery catheter system. The smallest transverse dimension that the graft member 10 can be constrained to for loading and delivery into and out of a suitable delivery catheter is the minimum transverse dimension. The minimum transverse dimension of the graft member 10 in a constrained state is about 4 mm, but can be up to about 6 mm. Preferably, the minimum transverse dimension of the graft member is about 2 to about 4 mm.
  • FIG. 4 is an elevational view of a delivery catheter [0032] 21 having a proximal end 22, a distal end 23, and a distal section 24. Luer connector 25 is disposed at the proximal end 22 of the delivery catheter. The delivery catheter 21 is constructed using common guiding or delivery catheter methods and can be of a solid polymer material or optionally can have a mesh, coil or braid of a suitable high strength metal or fiber embedded therein. FIG. 5 is a transverse cross sectional view of the delivery catheter 21 shown in FIG. 4 taken at lines 5-5 in FIG. 4 at the distal section 24 of the delivery catheter. The delivery catheter 21 has a lumen 26 extending the length of the catheter which has an inner diameter of about 4 to about 5 mm. The wall 27 of the distal section 24 has a thickness of about 0.01 inches, but can have a thickness of about 0.005 to about 0.05 inches. The length of the delivery catheter 21 is about 20 to about 50 cm, but can be about 10 to about 150 cm. The delivery catheter 21 preferably has a low friction surface inside the lumen to facilitate deployment of thin wall graft members. The wall 27 of the delivery catheter 21 is shown as having a single polymer layer, but may be constructed of multiple concentric or eccentric layers, preferably with the inner-most layer being of a low friction polymer such as TFE or high density polypropylene. Other suitable polymers for the delivery catheter 21 include polyurethane, polyvinylchloride, polyimide, polyamide and the like. The delivery catheter 21 may also optionally have more than one lumen, including a lumen for passage of a guidewire or similar device.
  • FIG. 6 shows a graft [0033] 31 having features of the invention deployed within a preselected portion 32 of a patient's body lumen 33. The preselected portion 32 of the patient's body lumen 33 has a distended portion 34 that is representative of an aortic aneurysm or the like. The body lumen 33 has a wall 35 that is engaged by the graft 31. A second or inner-most thin wall graft member 36 is disposed and deployed within a first thin wall graft member 37. A first end 38 of the second thin wall graft member 36 is extending longitudinally from a first end 41 of the first thin wall graft member 37 to provide a smooth transition for a flow of blood therethrough as indicated by arrow 39. Both the first and second thin wall graft members 36 and 37 completely span the preselected portion 32 of the patient's body lumen. The first end 41 of the first thin wall graft member 37 and the first end 38 of the second thin wall graft member are secured to a healthy tissue portion 42 of the body lumen 33. A second end 43 of the first thin wall graft member 37 and a second end 44 of the second thin wall graft member 36 are also secured to a healthy tissue portion 42 of the body lumen. Although the healthy tissue portion 42 of the patient's body lumen 33 is shown as having a constant diameter in FIG. 6, the term healthy tissue portion or is intended to mean any portion of a patient's body lumen or passageway that has sufficient strength or integrity to support an anchoring mechanism 12 and 13 of the type discussed herein above.
  • FIG. 7 is an elevational view of a bifurcated embodiment of a graft [0034] 50 having features of the invention shown in an expanded deployed state. A second thin wall graft member 51 is disposed within a first thin wall graft member 52. The first thin wall graft member 51 and the second thin wall graft member 52 each have a bifurcated configuration and each have a construction similar to that of the of the thin wall graft of FIGS. 1-3.
  • FIG. 8 is a transverse cross sectional view of the graft [0035] 50 of FIG. 7 taken at lines 8-8 of FIG. 7. The first thin wall graft member 52 is bifurcated and has a frame 53 and a membrane 54 within the frame. The second thin wall graft member 51 is disposed within the first thin wall graft member 52 and has a frame 55 and a membrane 56 within the frame. The cross section of the first thin wall member 52 and second thin wall member 51 is shown as round, but is sufficiently flexible to assume a variety of shapes necessary to engage an inside surface of a body lumen, including irregularly shaped body lumens. In addition, although the graft 50 of FIG. 7 is shown with two thin wall graft members 51 and 52, any suitable number of graft members could be used, so long as all portions of the graft 50 which span a preselected length of the patient's body lumen which is compromised have a sufficient number of graft member layers and structural strength to maintain a flow of blood therethrough and prevent leakage or failure of the patient's body lumen. The thin wall graft members 51 and 52 of FIG. 7 are shown as complete bifurcated embodiments, however, they may optionally be formed from multiple overlapping thin wall graft members that are individually either partially bifurcated or not bifurcated at all.

Claims (18)

What is claimed is:
1. An endovascular graft for supporting a preselected length of a patient's body lumen comprising a plurality of separate thin wall graft members configured to be layered in a deployed state with at least two of the thin wall graft members having a length greater than the preselected length of the patient's body lumen.
2. The endovascular graft of claim 1 wherein no single thin wall graft member has sufficient mechanical strength in a deployed state to provide a desired amount of support for the preselected length of a patient's body lumen.
3. The endovascular graft of claim 2 wherein the thin wall graft members are configured to provide sufficient mechanical strength to provide a desired amount of support for the preselected length of the patient's body lumen in portions of the graft where at least two of the thin wall graft members are overlapped.
4. The endovascular graft of claim 2 wherein the graft comprises at least 3 thin wall graft members and the thin wall graft members are configured to provide sufficient mechanical strength to provide a desired amount of support for the preselected portion of the patient's body lumen only in portions of the graft where all of the thin wall graft members are overlapped.
5. The graft of claim 1 wherein an inner most thin wall graft member has an axial length substantially greater than all other thin wall graft members such that the inner-most thin wall graft member can extend longitudinally beyond a distal end and a proximal end of all other thin wall graft members when deployed.
6. The graft of claim 1 wherein the thin wall graft members are configured to be expanded to a transverse dimension of up to about 40 mm and constrained to a maximum outer transverse dimension of down to about 3 mm.
7. The graft of claim 1 wherein the separate thin wall graft members are individually deliverable.
8. The graft of claim 1 wherein each thin wall graft member further comprises an anchoring mechanism at both ends and at least two of the thin wall graft members have a longitudinal length sufficient to span the preselected length of the patient's body lumen and engage tissue of sufficient integrity to support the anchoring mechanisms at both ends of the at least two thin wall graft members.
9. A method of deploying an endovascular graft within a body passageway of a patient comprising:
a) providing an endovascular graft comprising at least two thin wall graft members configured to be layered in a deployed state;
b) percutaneously delivering a first thin wall graft member through a low profile delivery catheter system to a desired site within a passageway of a patient's body and deploying the first thin wall graft member at the desired site;
c) percutaneously delivering a second thin wall graft member through a low profile delivery catheter system and positioning the second thin wall graft member within a longitudinal lumen of the deployed first thin wall graft member; and
d) deploying the second thin wall graft member within the longitudinal lumen of the deployed first thin wall graft member.
10. The method of claim 9 wherein an inner most thin wall graft member extends longitudinally beyond the other thin wall graft members and engages the artery wall directly.
11. A method of deploying an endovascular graft within a body passageway of a patient comprising:
a) providing an endovascular graft comprising at least two thin wall graft members configured to be layered in a deployed state;
b) percutaneously delivering a first thin wall graft member through a low profile delivery catheter system to a preselected site within a passageway of a patient's body;
c) percutaneously delivering a second thin wall graft member through a low profile delivery catheter system and positioning the second thin wall graft member within a longitudinal lumen of the first thin wall graft member; and
d) deploying the second thin wall graft member within the longitudinal lumen of the deployed first thin wall graft member and simultaneously deploying the first thin wall graft member until the first and second thin wall graft members are in a desired configuration within the passageway of the patient.
12. The method of claim 11 wherein an inner most thin wall graft member extends longitudinally beyond the other thin wall graft members and engages the artery wall directly.
13. The method of claim 11 wherein the passageway of the patient has a curvature and the thin wall graft members are progressively deployed such that each added thin wall graft member is offset in the same longitudinal direction through the curvature of the patient's body passageway so that there are at least two layers of thin wall graft member over every portion of the preselected length of the patient's body passageway but each added thin wall graft member adds to the length of the graft in the amount of longitudinal offset and is sufficiently short in longitudinal length to absorb the curvature of the passageway without undue kinking or folding.
14. A kit comprising an endovascular graft having at least a first thin wall graft member and a second thin wall graft member with the second thin wall graft member configured to fit and be deployed within a longitudinal lumen of the first thin wall graft member.
15. The kit of claim 14 wherein the first and second thin wall graft members configured to be deployed within a low profile delivery catheter system.
16. The kit of claim 15 wherein the first and second thin wall graft members are configured to be delivered through a delivery catheter system with a maximum distal outer transverse dimension of up to about 4 mm.
17. An endovascular graft for supporting a preselected length of a patient's body lumen comprising a plurality of thin wall graft members that are linked so as to allow relative longitudinal movement and that are configured to be layered in a deployed state with at least two of the thin wall graft members having a length greater than the preselected length of the patient's body lumen.
18. The endovascular graft of claim 17 wherein the plurality of thin wall graft members are configured to be telescopically linked to allow for longitudinal extension during delivery and layering in a deployed state.
US09/970,576 1997-11-25 2001-10-04 Layered endovascular graft Abandoned US20020010508A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/970,576 US20020010508A1 (en) 1997-11-25 2001-10-04 Layered endovascular graft
US10/803,153 US20040220664A1 (en) 1997-11-25 2004-03-17 Layered endovascular graft

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6630197P 1997-11-25 1997-11-25
US09/200,317 US6331191B1 (en) 1997-11-25 1998-11-25 Layered endovascular graft
US09/970,576 US20020010508A1 (en) 1997-11-25 2001-10-04 Layered endovascular graft

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/200,317 Continuation US6331191B1 (en) 1997-11-25 1998-11-25 Layered endovascular graft

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/803,153 Continuation US20040220664A1 (en) 1997-11-25 2004-03-17 Layered endovascular graft

Publications (1)

Publication Number Publication Date
US20020010508A1 true US20020010508A1 (en) 2002-01-24

Family

ID=22068639

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/200,317 Expired - Fee Related US6331191B1 (en) 1997-11-25 1998-11-25 Layered endovascular graft
US09/970,576 Abandoned US20020010508A1 (en) 1997-11-25 2001-10-04 Layered endovascular graft
US10/803,153 Abandoned US20040220664A1 (en) 1997-11-25 2004-03-17 Layered endovascular graft

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/200,317 Expired - Fee Related US6331191B1 (en) 1997-11-25 1998-11-25 Layered endovascular graft

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/803,153 Abandoned US20040220664A1 (en) 1997-11-25 2004-03-17 Layered endovascular graft

Country Status (3)

Country Link
US (3) US6331191B1 (en)
EP (3) EP1625833A3 (en)
WO (1) WO1999026559A1 (en)

Cited By (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040138734A1 (en) * 2001-04-11 2004-07-15 Trivascular, Inc. Delivery system and method for bifurcated graft
US20040210304A1 (en) * 1999-11-17 2004-10-21 Corevalve, S.A. Prosthetic valve for transluminal delivery
US20050055088A1 (en) * 2000-06-30 2005-03-10 Liddicoat John R. Method and apparatus for performing a procedure on a cardiac valve
US20050261669A1 (en) * 1998-04-30 2005-11-24 Medtronic, Inc. Intracardiovascular access (ICVA™) system
US20060129235A1 (en) * 1999-11-17 2006-06-15 Jacques Seguin Prosthetic valve for transluminal delivery
US20060259136A1 (en) * 2005-05-13 2006-11-16 Corevalve Sa Heart valve prosthesis and methods of manufacture and use
US20070043435A1 (en) * 1999-11-17 2007-02-22 Jacques Seguin Non-cylindrical prosthetic valve system for transluminal delivery
US20070173932A1 (en) * 2002-09-23 2007-07-26 3F Therapeutics, Inc. Prosthetic mitral valve
US20070185513A1 (en) * 2001-06-29 2007-08-09 Woolfson Steven B Method and apparatus for resecting and replacing an aortic valve
US20070233228A1 (en) * 2006-03-28 2007-10-04 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US20080015671A1 (en) * 2004-11-19 2008-01-17 Philipp Bonhoeffer Method And Apparatus For Treatment Of Cardiac Valves
US20080039774A1 (en) * 2003-02-21 2008-02-14 C.R. Bard, Inc. Multi-lumen catheter with separate distal tips
US20080071363A1 (en) * 2006-09-19 2008-03-20 Yosi Tuval Valve prosthesis fixation techniques using sandwiching
US20080140189A1 (en) * 2006-12-06 2008-06-12 Corevalve, Inc. System and method for transapical delivery of an annulus anchored self-expanding valve
US20080243246A1 (en) * 2007-02-16 2008-10-02 Ryan Timothy R Replacement prosthetic heart valves and methods of implantation
US20080262593A1 (en) * 2007-02-15 2008-10-23 Ryan Timothy R Multi-layered stents and methods of implanting
US20090088833A1 (en) * 2007-09-28 2009-04-02 Maximiliano Soetermans Double wall stent with retrieval member
US20090171451A1 (en) * 2007-12-27 2009-07-02 Cook Incorporated Implantable device having composite weave
US20090192585A1 (en) * 2008-01-24 2009-07-30 Medtronic, Inc. Delivery Systems and Methods of Implantation for Prosthetic Heart Valves
US20090192586A1 (en) * 2008-01-24 2009-07-30 Medtronic, Inc. Delivery Systems for Prosthetic Heart Valves
US20090254165A1 (en) * 2008-01-24 2009-10-08 Medtronic,Inc. Delivery Systems and Methods of Implantation for Prosthetic Heart Valves
US20090259292A1 (en) * 2008-04-08 2009-10-15 Medtronic, Inc. Multiple Orifice Implantable Heart Valve and Methods of Implantation
US20090264989A1 (en) * 2008-02-28 2009-10-22 Philipp Bonhoeffer Prosthetic heart valve systems
US20090287290A1 (en) * 2008-01-24 2009-11-19 Medtronic, Inc. Delivery Systems and Methods of Implantation for Prosthetic Heart Valves
US20090292350A1 (en) * 2008-01-24 2009-11-26 Medtronic, Inc. Stents for Prosthetic Heart Valves
US20100004740A1 (en) * 1999-11-17 2010-01-07 Jacques Seguin Prosthetic Valve for Transluminal Delivery
US20100016943A1 (en) * 2001-12-20 2010-01-21 Trivascular2, Inc. Method of delivering advanced endovascular graft
US20100023120A1 (en) * 2008-04-23 2010-01-28 Holecek Arin N Tissue attachment devices and methods for prosthetic heart valves
US20100018447A1 (en) * 2008-04-23 2010-01-28 Holecek Arin N Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US20100030244A1 (en) * 2001-09-07 2010-02-04 Woolfson Steven B Fixation band for affixing a prosthetic heart valve to tissue
US20100036485A1 (en) * 2001-07-04 2010-02-11 Medtronic Corevalve Llc Assembly For Placing A Prosthetic Valve In A Duct In The Body
US20100069852A1 (en) * 2008-09-17 2010-03-18 Gregory Scott Kelley Delivery system for deployment of medical devices
US7682390B2 (en) 2001-07-31 2010-03-23 Medtronic, Inc. Assembly for setting a valve prosthesis in a corporeal duct
US20100094411A1 (en) * 2008-10-13 2010-04-15 Vector Technologies, Ltd. Prosthetic valve having tapered tip when compressed for delivery
US20100100176A1 (en) * 2003-10-06 2010-04-22 Ats Medical, Inc. Anchoring structure with concave landing zone
US20100121436A1 (en) * 2008-09-15 2010-05-13 Yossi Tuval Prosthetic Heart Valve Having Identifiers for Aiding in Radiographic Positioning
US20100262231A1 (en) * 2006-09-19 2010-10-14 Yossi Tuval Sinus-Engaging Valve Fixation Member
US20100280540A1 (en) * 2000-06-30 2010-11-04 Streeter Richard B Intravascular Filter with Debris Entrapment Mechanism
US20110082539A1 (en) * 2009-10-05 2011-04-07 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US7972378B2 (en) 2008-01-24 2011-07-05 Medtronic, Inc. Stents for prosthetic heart valves
US20110208283A1 (en) * 2010-02-24 2011-08-25 Rust Matthew J Transcatheter valve structure and methods for valve delivery
US8070801B2 (en) 2001-06-29 2011-12-06 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8109996B2 (en) 2004-03-03 2012-02-07 Sorin Biomedica Cardio, S.R.L. Minimally-invasive cardiac-valve prosthesis
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US8506620B2 (en) 2005-09-26 2013-08-13 Medtronic, Inc. Prosthetic cardiac and venous valves
US8512397B2 (en) 2009-04-27 2013-08-20 Sorin Group Italia S.R.L. Prosthetic vascular conduit
US20130243937A1 (en) * 2003-11-25 2013-09-19 Boston Scientific Scimed, Inc. Composite stent with inner and outer stent elements and method of using the same
US8540768B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US8623077B2 (en) 2001-06-29 2014-01-07 Medtronic, Inc. Apparatus for replacing a cardiac valve
US8652204B2 (en) 2010-04-01 2014-02-18 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US8685084B2 (en) 2011-12-29 2014-04-01 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US8784478B2 (en) 2006-10-16 2014-07-22 Medtronic Corevalve, Inc. Transapical delivery system with ventruculo-arterial overlfow bypass
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
US8951280B2 (en) 2000-11-09 2015-02-10 Medtronic, Inc. Cardiac valve procedure methods and devices
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
US9089422B2 (en) 2008-01-24 2015-07-28 Medtronic, Inc. Markers for prosthetic heart valves
US9161836B2 (en) 2011-02-14 2015-10-20 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9237886B2 (en) 2007-04-20 2016-01-19 Medtronic, Inc. Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US9248017B2 (en) 2010-05-21 2016-02-02 Sorin Group Italia S.R.L. Support device for valve prostheses and corresponding kit
US9289289B2 (en) 2011-02-14 2016-03-22 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9629718B2 (en) 2013-05-03 2017-04-25 Medtronic, Inc. Valve delivery tool
US9775704B2 (en) 2004-04-23 2017-10-03 Medtronic3F Therapeutics, Inc. Implantable valve prosthesis
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US9918833B2 (en) 2010-09-01 2018-03-20 Medtronic Vascular Galway Prosthetic valve support structure
US10188516B2 (en) 2007-08-20 2019-01-29 Medtronic Ventor Technologies Ltd. Stent loading tool and method for use thereof
US10856970B2 (en) 2007-10-10 2020-12-08 Medtronic Ventor Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US11304802B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US11951007B2 (en) 2020-04-13 2024-04-09 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625833A3 (en) * 1997-11-25 2010-09-22 TriVascular2, Inc. Layered endovascular graft
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6733513B2 (en) 1999-11-04 2004-05-11 Advanced Bioprosthetic Surfaces, Ltd. Balloon catheter having metal balloon and method of making same
US7226475B2 (en) * 1999-11-09 2007-06-05 Boston Scientific Scimed, Inc. Stent with variable properties
US6428569B1 (en) * 1999-11-09 2002-08-06 Scimed Life Systems Inc. Micro structure stent configurations
US8458879B2 (en) * 2001-07-03 2013-06-11 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Method of fabricating an implantable medical device
US6602280B2 (en) 2000-02-02 2003-08-05 Trivascular, Inc. Delivery system and method for expandable intracorporeal device
US6613078B1 (en) * 2000-08-02 2003-09-02 Hector Daniel Barone Multi-component endoluminal graft assembly, use thereof and method of implanting
US20010044650A1 (en) * 2001-01-12 2001-11-22 Simso Eric J. Stent for in-stent restenosis
US7560006B2 (en) * 2001-06-11 2009-07-14 Boston Scientific Scimed, Inc. Pressure lamination method for forming composite ePTFE/textile and ePTFE/stent/textile prostheses
US6695920B1 (en) 2001-06-27 2004-02-24 Advanced Cardiovascular Systems, Inc. Mandrel for supporting a stent and a method of using the mandrel to coat a stent
US6579307B2 (en) 2001-07-19 2003-06-17 The Cleveland Clinic Foundation Endovascular prosthesis having a layer of biological tissue
US7377938B2 (en) * 2001-07-19 2008-05-27 The Cleveland Clinic Foundation Prosthetic cardiac value and method for making same
US7125464B2 (en) 2001-12-20 2006-10-24 Boston Scientific Santa Rosa Corp. Method for manufacturing an endovascular graft section
US7131991B2 (en) * 2002-04-24 2006-11-07 Medtronic Vascular, Inc. Endoluminal prosthetic assembly and extension method
DE10219014A1 (en) * 2002-04-27 2003-11-13 Ruesch Willy Gmbh Self-expanding stent for reinforcing and/or keeping open a hollow organ comprise two elastic tubular layers which bracket and positionally fix at least one helical filament
ATE468828T1 (en) * 2002-06-28 2010-06-15 Cook Inc THORACIC AORTIC ANEURYSMA STENT IMPLANT
US7722657B2 (en) * 2002-08-23 2010-05-25 William A. Cook Australia Pty. Ltd. Asymmetric stent graft attachment
US7217287B2 (en) 2002-08-28 2007-05-15 Heart Leaflet Technologies, Inc. Method of treating diseased valve
EP1542616B1 (en) * 2002-09-20 2015-04-22 Endologix, Inc. Stent-graft with positioning anchor
US20040059406A1 (en) * 2002-09-20 2004-03-25 Cully Edward H. Medical device amenable to fenestration
AU2003270817B2 (en) 2002-09-26 2009-09-17 Vactronix Scientific, Llc High strength vacuum deposited nitionol alloy films, medical thin film graft materials and method of making same
US20040098096A1 (en) * 2002-10-22 2004-05-20 The University Of Miami Endograft device to inhibit endoleak and migration
US7074276B1 (en) 2002-12-12 2006-07-11 Advanced Cardiovascular Systems, Inc. Clamp mandrel fixture and a method of using the same to minimize coating defects
US7354480B1 (en) * 2003-02-26 2008-04-08 Advanced Cardiovascular Systems, Inc. Stent mandrel fixture and system for reducing coating defects
US7025779B2 (en) * 2003-02-26 2006-04-11 Scimed Life Systems, Inc. Endoluminal device having enhanced affixation characteristics
US7150758B2 (en) * 2003-03-06 2006-12-19 Boston Scientific Santa Rosa Corp. Kink resistant endovascular graft
US7452374B2 (en) * 2003-04-24 2008-11-18 Maquet Cardiovascular, Llc AV grafts with rapid post-operative self-sealing capabilities
US20050131520A1 (en) * 2003-04-28 2005-06-16 Zilla Peter P. Compliant blood vessel graft
US7998188B2 (en) 2003-04-28 2011-08-16 Kips Bay Medical, Inc. Compliant blood vessel graft
CA2523812C (en) * 2003-04-28 2011-06-21 Medtronic, Inc. Compliant venous graft
CN101005812A (en) 2003-05-07 2007-07-25 先进生物假体表面有限公司 Metallic implantable grafts and method of making same
US8052701B1 (en) * 2003-06-02 2011-11-08 Abbott Cardiovascular Systems Inc. Method and apparatus for rupturing a vulnerable plaque
US7247986B2 (en) * 2003-06-10 2007-07-24 Samsung Sdi. Co., Ltd. Organic electro luminescent display and method for fabricating the same
US7632291B2 (en) 2003-06-13 2009-12-15 Trivascular2, Inc. Inflatable implant
WO2005025456A1 (en) * 2003-09-02 2005-03-24 University Of Florida Polymeric reconstrainable, repositionable, detachable, percutaneous endovascular stentgraft
US7530994B2 (en) * 2003-12-30 2009-05-12 Scimed Life Systems, Inc. Non-porous graft with fastening elements
WO2005079339A2 (en) * 2004-02-12 2005-09-01 The University Of Akron Improved stent for use in arteries
US8048145B2 (en) 2004-07-22 2011-11-01 Endologix, Inc. Graft systems having filling structures supported by scaffolds and methods for their use
US20060233991A1 (en) 2005-04-13 2006-10-19 Trivascular, Inc. PTFE layers and methods of manufacturing
CN101247773B (en) 2005-05-27 2010-12-15 心叶科技公司 Stentless support structure
US8663312B2 (en) * 2005-05-27 2014-03-04 Hlt, Inc. Intravascular cuff
AU2011265440B2 (en) * 2005-05-27 2013-04-04 Hlt, Inc. Stentless support structure
US7823533B2 (en) 2005-06-30 2010-11-02 Advanced Cardiovascular Systems, Inc. Stent fixture and method for reducing coating defects
EP1903985A4 (en) 2005-07-07 2010-04-28 Nellix Inc Systems and methods for endovascular aneurysm treatment
DE102006020687A1 (en) * 2005-07-19 2007-02-08 Aesculap Ag & Co. Kg Stent graft prosthesis for treating abdominal aneurisms and aneurisms of the thoracal aorta comprises a sleeve formed as a folding toroid and having a shape in the unfolded state which fits the shape of the aneurism
US7735449B1 (en) 2005-07-28 2010-06-15 Advanced Cardiovascular Systems, Inc. Stent fixture having rounded support structures and method for use thereof
US7731741B2 (en) * 2005-09-08 2010-06-08 Boston Scientific Scimed, Inc. Inflatable bifurcation stent
US8043366B2 (en) 2005-09-08 2011-10-25 Boston Scientific Scimed, Inc. Overlapping stent
US8343204B2 (en) * 2005-10-31 2013-01-01 Cook Medical Technologies Llc Composite stent graft
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
US20070179599A1 (en) * 2006-01-31 2007-08-02 Icon Medical Corp. Vascular protective device
EP1991164B1 (en) * 2006-02-28 2017-06-14 Angiomed GmbH & Co. Medizintechnik KG Flexible stretch stent-graft
US20100036475A1 (en) * 2006-04-27 2010-02-11 Wilifrido Castaneda Methods and apparatus for extraluminal femoropopliteal bypass graft
US7985441B1 (en) 2006-05-04 2011-07-26 Yiwen Tang Purification of polymers for coating applications
US8069814B2 (en) 2006-05-04 2011-12-06 Advanced Cardiovascular Systems, Inc. Stent support devices
US8216297B2 (en) * 2006-08-14 2012-07-10 Trivascular, Inc. Dual chamber cuff structure
JP5106537B2 (en) * 2006-09-28 2012-12-26 ハート リーフレット テクノロジーズ, インコーポレイテッド Delivery tool for transdermal delivery of prostheses
KR100847123B1 (en) * 2006-11-22 2008-07-18 주식회사 스텐다드싸이텍 Stent
PL2124831T3 (en) 2007-03-15 2017-03-31 Ortho-Space Ltd. Prosthetic devices
CA2697364C (en) 2007-08-23 2017-10-17 Direct Flow Medical, Inc. Translumenally implantable heart valve with formed in place support
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
CN101917929A (en) 2007-10-04 2010-12-15 特里瓦斯库拉尔公司 Modular vascular graft for low profile percutaneous delivery
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US20090138065A1 (en) * 2007-11-28 2009-05-28 Wilson-Cook Medical Inc. Double loaded stent delivery system
WO2009086269A2 (en) * 2007-12-21 2009-07-09 Massachusetts Institute Of Technology Endovascular devices/catheter platforms and methods for achieving congruency in sequentially deployed devices
AU2009240419A1 (en) 2008-04-25 2009-10-29 Nellix, Inc. Stent graft delivery system
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
EP2280755A1 (en) 2008-05-01 2011-02-09 Aneuclose LLC Aneurysm occlusion device
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
CA2726596A1 (en) 2008-06-04 2009-12-10 Nellix, Inc. Sealing apparatus and methods of use
US8709080B2 (en) * 2008-09-19 2014-04-29 E. Benson Hood Laboratories Coated devices comprising a fiber mesh imbedded in the device walls
US9427304B2 (en) * 2008-10-27 2016-08-30 St. Jude Medical, Cardiology Division, Inc. Multi-layer device with gap for treating a target site and associated method
US8858613B2 (en) 2010-09-20 2014-10-14 Altura Medical, Inc. Stent graft delivery systems and associated methods
GB2472603B (en) * 2009-08-11 2011-12-14 Cook Medical Technologies Llc Implantable medical device
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
EP2559404A3 (en) 2009-12-01 2014-10-29 Altura Medical, Inc. Modular endograft devices and associated systems and methods
US20110276078A1 (en) 2009-12-30 2011-11-10 Nellix, Inc. Filling structure for a graft system and methods of use
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US20110218609A1 (en) * 2010-02-10 2011-09-08 Trivascular, Inc. Fill tube manifold and delivery methods for endovascular graft
JP5827991B2 (en) 2010-05-10 2015-12-02 エイチエルティー, インコーポレイテッド Stentless support structure
US9603708B2 (en) 2010-05-19 2017-03-28 Dfm, Llc Low crossing profile delivery catheter for cardiovascular prosthetic implant
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
US8696737B2 (en) 2010-08-11 2014-04-15 Hlt, Inc. Reinforced commissural support structure
US8801768B2 (en) 2011-01-21 2014-08-12 Endologix, Inc. Graft systems having semi-permeable filling structures and methods for their use
CN103648437B (en) 2011-04-06 2016-05-04 恩朵罗杰克斯国际控股有限公司 For the method and system of vascular aneurysms treatment
US9522064B2 (en) 2011-05-16 2016-12-20 Hlt, Inc. Inversion delivery device and method for a prosthesis
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
US9289307B2 (en) 2011-10-18 2016-03-22 Ortho-Space Ltd. Prosthetic devices and methods for using same
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US9445897B2 (en) 2012-05-01 2016-09-20 Direct Flow Medical, Inc. Prosthetic implant delivery device with introducer catheter
US8955520B2 (en) * 2012-07-19 2015-02-17 Cook Medical Technologies Llc Method of placing multiple biliary stents without re-intervention, and device for same
AU2013299425A1 (en) 2012-08-10 2015-03-19 Altura Medical, Inc. Stent delivery systems and associated methods
WO2014159093A1 (en) 2013-03-14 2014-10-02 Endologix, Inc. Method for forming materials in situ within a medical device
CN105208973B (en) 2013-03-15 2018-04-03 Hlt股份有限公司 Low profile prosthetic valve structures
WO2014144809A1 (en) 2013-03-15 2014-09-18 Altura Medical, Inc. Endograft device delivery systems and associated methods
US9907684B2 (en) 2013-05-08 2018-03-06 Aneuclose Llc Method of radially-asymmetric stent expansion
WO2016061139A1 (en) 2014-10-13 2016-04-21 Hlt, Inc. Inversion delivery device and method for a prosthesis
US10959761B2 (en) 2015-09-18 2021-03-30 Ortho-Space Ltd. Intramedullary fixated subacromial spacers
JP6902044B2 (en) 2016-03-17 2021-07-14 インテュイティブ サージカル オペレーションズ, インコーポレイテッド Systems and methods for instrument insertion control
KR102437404B1 (en) 2016-07-14 2022-08-30 인튜어티브 서지컬 오퍼레이션즈 인코포레이티드 Systems and methods for controlling surgical instruments
US11045981B2 (en) 2017-01-30 2021-06-29 Ortho-Space Ltd. Processing machine and methods for processing dip-molded articles
CN110325138B (en) 2017-03-22 2023-06-06 直观外科手术操作公司 System and method for intelligent seed registration

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814137A (en) * 1973-01-26 1974-06-04 Baxter Laboratories Inc Injection site for flow conduits containing biological fluids
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US5064435A (en) * 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5354329A (en) * 1992-04-17 1994-10-11 Whalen Biomedical, Inc. Vascular prosthesis having enhanced compatibility and compliance characteristics
US5582724A (en) * 1992-06-10 1996-12-10 International Separation Technology, Inc. Centrifuge and rotor for use therein
DE4334140C2 (en) * 1993-10-07 1996-04-18 Angiomed Ag Stent and device with stent
WO1995010989A1 (en) * 1993-10-19 1995-04-27 Scimed Life Systems, Inc. Intravascular stent pump
US5639278A (en) * 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5855598A (en) * 1993-10-21 1999-01-05 Corvita Corporation Expandable supportive branched endoluminal grafts
DE9319267U1 (en) * 1993-12-15 1994-02-24 Vorwerk Dierk Dr Aortic endoprosthesis
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US6165213A (en) * 1994-02-09 2000-12-26 Boston Scientific Technology, Inc. System and method for assembling an endoluminal prosthesis
US6051020A (en) * 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
DE4418336A1 (en) * 1994-05-26 1995-11-30 Angiomed Ag Stent for widening and holding open receptacles
DE29522101U1 (en) * 1994-06-08 1999-12-09 Cardiovascular Concepts Inc Endoluminal prosthesis
US5755770A (en) * 1995-01-31 1998-05-26 Boston Scientific Corporatiion Endovascular aortic graft
US5683449A (en) * 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5662675A (en) 1995-02-24 1997-09-02 Intervascular, Inc. Delivery catheter assembly
US6124523A (en) * 1995-03-10 2000-09-26 Impra, Inc. Encapsulated stent
JP3507503B2 (en) * 1995-03-10 2004-03-15 インプラ・インコーポレーテッド Sealable stent for body cavity, method for producing the same, and method for introducing the same into body cavity
US5709713A (en) * 1995-03-31 1998-01-20 Cardiovascular Concepts, Inc. Radially expansible vascular prosthesis having reversible and other locking structures
US5667523A (en) * 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
CA2223479A1 (en) * 1995-06-08 1996-12-27 Bard Galway Limited Endovascular stent
US5769882A (en) * 1995-09-08 1998-06-23 Medtronic, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
US6193745B1 (en) * 1995-10-03 2001-02-27 Medtronic, Inc. Modular intraluminal prosteheses construction and methods
US6045557A (en) * 1995-11-10 2000-04-04 Baxter International Inc. Delivery catheter and method for positioning an intraluminal graft
US6576009B2 (en) * 1995-12-01 2003-06-10 Medtronic Ave, Inc. Bifurcated intraluminal prostheses construction and methods
US5824040A (en) * 1995-12-01 1998-10-20 Medtronic, Inc. Endoluminal prostheses and therapies for highly variable body lumens
US6042605A (en) * 1995-12-14 2000-03-28 Gore Enterprose Holdings, Inc. Kink resistant stent-graft
US6203569B1 (en) * 1996-01-04 2001-03-20 Bandula Wijay Flexible stent
US5843160A (en) * 1996-04-01 1998-12-01 Rhodes; Valentine J. Prostheses for aneurysmal and/or occlusive disease at a bifurcation in a vessel, duct, or lumen
US5824042A (en) * 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
DE19614160A1 (en) * 1996-04-10 1997-10-16 Variomed Ag Stent for transluminal implantation in hollow organs
FR2748198B1 (en) * 1996-05-02 1998-08-21 Braun Celsa Sa PROSTHESIS IN PARTICULAR FOR THE TREATMENT OF ANNEVRISMS OVERFLOWING ON ILIAC VESSELS
FR2748199B1 (en) * 1996-05-02 1998-10-09 Braun Celsa Sa TRANSCUTANEOUS SURGICAL ANASTOMOSABLE VASCULAR PROSTHESIS
JP3009848B2 (en) * 1996-06-11 2000-02-14 住友重機械工業株式会社 Inner roller and outer roller of internal meshing planetary gear structure and method of manufacturing the same
US6174326B1 (en) * 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production
US5755776A (en) * 1996-10-04 1998-05-26 Al-Saadon; Khalid Permanent expandable intraluminal tubular stent
US6551350B1 (en) * 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
US6015431A (en) * 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
US6117168A (en) * 1996-12-31 2000-09-12 Scimed Life Systems, Inc. Multilayer liquid absorption and deformation devices
BE1010858A4 (en) * 1997-01-16 1999-02-02 Medicorp R & D Benelux Sa Luminal endoprosthesis FOR BRANCHING.
US5961545A (en) * 1997-01-17 1999-10-05 Meadox Medicals, Inc. EPTFE graft-stent composite device
US5858556A (en) * 1997-01-21 1999-01-12 Uti Corporation Multilayer composite tubular structure and method of making
ATE275888T1 (en) * 1997-01-29 2004-10-15 Endovascular Tech Inc MODULAR STENT FABRIC WITH BELL-SHAPED EXTENDED END
US5853419A (en) * 1997-03-17 1998-12-29 Surface Genesis, Inc. Stent
DE19720115C2 (en) * 1997-05-14 1999-05-20 Jomed Implantate Gmbh Stent graft
US5836966A (en) * 1997-05-22 1998-11-17 Scimed Life Systems, Inc. Variable expansion force stent
US5984955A (en) * 1997-09-11 1999-11-16 Wisselink; Willem System and method for endoluminal grafting of bifurcated or branched vessels
US6030414A (en) * 1997-11-13 2000-02-29 Taheri; Syde A. Variable stent and method for treatment of arterial disease
US5931865A (en) * 1997-11-24 1999-08-03 Gore Enterprise Holdings, Inc. Multiple-layered leak resistant tube
EP1625833A3 (en) * 1997-11-25 2010-09-22 TriVascular2, Inc. Layered endovascular graft
US6102918A (en) * 1998-02-18 2000-08-15 Montefiore Hospital And Medical Center Collapsible low-profile vascular graft implantation instrument and method for use thereof
US6129756A (en) * 1998-03-16 2000-10-10 Teramed, Inc. Biluminal endovascular graft system
US6093203A (en) * 1998-05-13 2000-07-25 Uflacker; Renan Stent or graft support structure for treating bifurcated vessels having different diameter portions and methods of use and implantation
ATE342014T1 (en) * 1998-06-19 2006-11-15 Endologix Inc SELF-EXPANDING BRANCHING ENDOVASCULAR PROSTHESIS
US6368345B1 (en) * 1998-09-30 2002-04-09 Edwards Lifesciences Corporation Methods and apparatus for intraluminal placement of a bifurcated intraluminal garafat
DE29822381U1 (en) * 1998-12-16 1999-03-18 Fumedica Intertrade Ag Device for inserting an aortic endoprosthesis
US6325823B1 (en) * 1999-10-29 2001-12-04 Revasc Corporation Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use
US6409756B1 (en) * 2000-01-24 2002-06-25 Edward G. Murphy Endovascular aortic graft
CA2400072C (en) * 2000-03-14 2010-01-19 Cook Incorporated Endovascular stent graft
US6602272B2 (en) * 2000-11-02 2003-08-05 Advanced Cardiovascular Systems, Inc. Devices configured from heat shaped, strain hardened nickel-titanium
ATE346568T1 (en) * 2001-03-28 2006-12-15 Cook Inc MODULAR STENT END PROSTHESIS

Cited By (218)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10485976B2 (en) 1998-04-30 2019-11-26 Medtronic, Inc. Intracardiovascular access (ICVA™) system
US20050261669A1 (en) * 1998-04-30 2005-11-24 Medtronic, Inc. Intracardiovascular access (ICVA™) system
US8998979B2 (en) 1999-11-17 2015-04-07 Medtronic Corevalve Llc Transcatheter heart valves
US20100152840A1 (en) * 1999-11-17 2010-06-17 Jacques Seguin Prosthetic Valve for Transluminal Delivery
US20100004740A1 (en) * 1999-11-17 2010-01-07 Jacques Seguin Prosthetic Valve for Transluminal Delivery
US10219901B2 (en) 1999-11-17 2019-03-05 Medtronic CV Luxembourg S.a.r.l. Prosthetic valve for transluminal delivery
US20070043435A1 (en) * 1999-11-17 2007-02-22 Jacques Seguin Non-cylindrical prosthetic valve system for transluminal delivery
US9962258B2 (en) 1999-11-17 2018-05-08 Medtronic CV Luxembourg S.a.r.l. Transcatheter heart valves
USRE45865E1 (en) 1999-11-17 2016-01-26 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US9066799B2 (en) 1999-11-17 2015-06-30 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US9060856B2 (en) 1999-11-17 2015-06-23 Medtronic Corevalve Llc Transcatheter heart valves
US8876896B2 (en) 1999-11-17 2014-11-04 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US20060129235A1 (en) * 1999-11-17 2006-06-15 Jacques Seguin Prosthetic valve for transluminal delivery
US20040210304A1 (en) * 1999-11-17 2004-10-21 Corevalve, S.A. Prosthetic valve for transluminal delivery
US7329278B2 (en) 1999-11-17 2008-02-12 Corevalve, Inc. Prosthetic valve for transluminal delivery
US8801779B2 (en) 1999-11-17 2014-08-12 Medtronic Corevalve, Llc Prosthetic valve for transluminal delivery
US8721708B2 (en) 1999-11-17 2014-05-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8603159B2 (en) 1999-11-17 2013-12-10 Medtronic Corevalve, Llc Prosthetic valve for transluminal delivery
US8579966B2 (en) * 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8016877B2 (en) 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US20090164006A1 (en) * 1999-11-17 2009-06-25 Jacques Seguin Prosthetic valve for transluminal delivery
US20110213461A1 (en) * 1999-11-17 2011-09-01 Medtronic Corevalve Llc Prosthetic Valve for Transluminal Delivery
US20110125257A1 (en) * 1999-11-17 2011-05-26 Medtronic Corevalve Llc Prosthetic Valve For Transluminal Delivery
US7892281B2 (en) 1999-11-17 2011-02-22 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8986329B2 (en) 1999-11-17 2015-03-24 Medtronic Corevalve Llc Methods for transluminal delivery of prosthetic valves
US9949831B2 (en) 2000-01-19 2018-04-24 Medtronics, Inc. Image-guided heart valve placement
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US10335280B2 (en) 2000-01-19 2019-07-02 Medtronic, Inc. Method for ablating target tissue of a patient
US20050055088A1 (en) * 2000-06-30 2005-03-10 Liddicoat John R. Method and apparatus for performing a procedure on a cardiac valve
US8092487B2 (en) 2000-06-30 2012-01-10 Medtronic, Inc. Intravascular filter with debris entrapment mechanism
US20100280540A1 (en) * 2000-06-30 2010-11-04 Streeter Richard B Intravascular Filter with Debris Entrapment Mechanism
US8777980B2 (en) 2000-06-30 2014-07-15 Medtronic, Inc. Intravascular filter with debris entrapment mechanism
US20100217384A1 (en) * 2000-06-30 2010-08-26 Medtronic Vascular, Inc. Method For Replacing Native Valve Function Of A Diseased Aortic Valve
US8951280B2 (en) 2000-11-09 2015-02-10 Medtronic, Inc. Cardiac valve procedure methods and devices
US20040138734A1 (en) * 2001-04-11 2004-07-15 Trivascular, Inc. Delivery system and method for bifurcated graft
US8771302B2 (en) 2001-06-29 2014-07-08 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8956402B2 (en) 2001-06-29 2015-02-17 Medtronic, Inc. Apparatus for replacing a cardiac valve
US8070801B2 (en) 2001-06-29 2011-12-06 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8623077B2 (en) 2001-06-29 2014-01-07 Medtronic, Inc. Apparatus for replacing a cardiac valve
US20070185513A1 (en) * 2001-06-29 2007-08-09 Woolfson Steven B Method and apparatus for resecting and replacing an aortic valve
US20100036485A1 (en) * 2001-07-04 2010-02-11 Medtronic Corevalve Llc Assembly For Placing A Prosthetic Valve In A Duct In The Body
US8002826B2 (en) 2001-07-04 2011-08-23 Medtronic Corevalve Llc Assembly for placing a prosthetic valve in a duct in the body
US8628570B2 (en) 2001-07-04 2014-01-14 Medtronic Corevalve Llc Assembly for placing a prosthetic valve in a duct in the body
US9149357B2 (en) 2001-07-04 2015-10-06 Medtronic CV Luxembourg S.a.r.l. Heart valve assemblies
US7682390B2 (en) 2001-07-31 2010-03-23 Medtronic, Inc. Assembly for setting a valve prosthesis in a corporeal duct
US20100030244A1 (en) * 2001-09-07 2010-02-04 Woolfson Steven B Fixation band for affixing a prosthetic heart valve to tissue
US9539088B2 (en) 2001-09-07 2017-01-10 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US10342657B2 (en) 2001-09-07 2019-07-09 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US20100016943A1 (en) * 2001-12-20 2010-01-21 Trivascular2, Inc. Method of delivering advanced endovascular graft
US8241346B2 (en) 2001-12-20 2012-08-14 Trivascular, Inc. Endovascular graft and method of delivery
US8864814B2 (en) 2001-12-20 2014-10-21 Trivascular, Inc. Method of delivering advanced endovascular graft and system
US20070173932A1 (en) * 2002-09-23 2007-07-26 3F Therapeutics, Inc. Prosthetic mitral valve
US20080039774A1 (en) * 2003-02-21 2008-02-14 C.R. Bard, Inc. Multi-lumen catheter with separate distal tips
US20100100176A1 (en) * 2003-10-06 2010-04-22 Ats Medical, Inc. Anchoring structure with concave landing zone
US9579194B2 (en) 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
US20130243937A1 (en) * 2003-11-25 2013-09-19 Boston Scientific Scimed, Inc. Composite stent with inner and outer stent elements and method of using the same
US9005695B2 (en) * 2003-11-25 2015-04-14 Boston Scientific Scimed, Inc. Composite stent with inner and outer stent elements and method of using the same
US9867695B2 (en) 2004-03-03 2018-01-16 Sorin Group Italia S.R.L. Minimally-invasive cardiac-valve prosthesis
US8535373B2 (en) 2004-03-03 2013-09-17 Sorin Group Italia S.R.L. Minimally-invasive cardiac-valve prosthesis
US8109996B2 (en) 2004-03-03 2012-02-07 Sorin Biomedica Cardio, S.R.L. Minimally-invasive cardiac-valve prosthesis
US9775704B2 (en) 2004-04-23 2017-10-03 Medtronic3F Therapeutics, Inc. Implantable valve prosthesis
US20080015671A1 (en) * 2004-11-19 2008-01-17 Philipp Bonhoeffer Method And Apparatus For Treatment Of Cardiac Valves
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US9895223B2 (en) 2005-02-10 2018-02-20 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US9486313B2 (en) 2005-02-10 2016-11-08 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US8540768B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US8539662B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac-valve prosthesis
US8920492B2 (en) 2005-02-10 2014-12-30 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US9060857B2 (en) 2005-05-13 2015-06-23 Medtronic Corevalve Llc Heart valve prosthesis and methods of manufacture and use
US9504564B2 (en) 2005-05-13 2016-11-29 Medtronic Corevalve Llc Heart valve prosthesis and methods of manufacture and use
US11284997B2 (en) 2005-05-13 2022-03-29 Medtronic CV Luxembourg S.a.r.l Heart valve prosthesis and methods of manufacture and use
US10478291B2 (en) 2005-05-13 2019-11-19 Medtronic CV Luxembourg S.a.r.l Heart valve prosthesis and methods of manufacture and use
USD732666S1 (en) 2005-05-13 2015-06-23 Medtronic Corevalve, Inc. Heart valve prosthesis
US8226710B2 (en) 2005-05-13 2012-07-24 Medtronic Corevalve, Inc. Heart valve prosthesis and methods of manufacture and use
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
USD812226S1 (en) 2005-05-13 2018-03-06 Medtronic Corevalve Llc Heart valve prosthesis
US20060259136A1 (en) * 2005-05-13 2006-11-16 Corevalve Sa Heart valve prosthesis and methods of manufacture and use
US8506620B2 (en) 2005-09-26 2013-08-13 Medtronic, Inc. Prosthetic cardiac and venous valves
US8075615B2 (en) 2006-03-28 2011-12-13 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US20070233228A1 (en) * 2006-03-28 2007-10-04 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US9331328B2 (en) 2006-03-28 2016-05-03 Medtronic, Inc. Prosthetic cardiac valve from pericardium material and methods of making same
US10058421B2 (en) 2006-03-28 2018-08-28 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US9913714B2 (en) 2006-09-19 2018-03-13 Medtronic, Inc. Sinus-engaging valve fixation member
US8771346B2 (en) 2006-09-19 2014-07-08 Medtronic Ventor Technologies Ltd. Valve prosthetic fixation techniques using sandwiching
US10004601B2 (en) 2006-09-19 2018-06-26 Medtronic Ventor Technologies Ltd. Valve prosthesis fixation techniques using sandwiching
US11304800B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US9301834B2 (en) 2006-09-19 2016-04-05 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US11304801B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US10195033B2 (en) 2006-09-19 2019-02-05 Medtronic Ventor Technologies Ltd. Valve prosthesis fixation techniques using sandwiching
US9642704B2 (en) 2006-09-19 2017-05-09 Medtronic Ventor Technologies Ltd. Catheter for implanting a valve prosthesis
US9138312B2 (en) 2006-09-19 2015-09-22 Medtronic Ventor Technologies Ltd. Valve prostheses
US8052750B2 (en) 2006-09-19 2011-11-08 Medtronic Ventor Technologies Ltd Valve prosthesis fixation techniques using sandwiching
US20080071363A1 (en) * 2006-09-19 2008-03-20 Yosi Tuval Valve prosthesis fixation techniques using sandwiching
US11304802B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US8747460B2 (en) 2006-09-19 2014-06-10 Medtronic Ventor Technologies Ltd. Methods for implanting a valve prothesis
US8348995B2 (en) 2006-09-19 2013-01-08 Medtronic Ventor Technologies, Ltd. Axial-force fixation member for valve
US9827097B2 (en) 2006-09-19 2017-11-28 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US9387071B2 (en) 2006-09-19 2016-07-12 Medtronic, Inc. Sinus-engaging valve fixation member
US8771345B2 (en) 2006-09-19 2014-07-08 Medtronic Ventor Technologies Ltd. Valve prosthesis fixation techniques using sandwiching
US20100262231A1 (en) * 2006-09-19 2010-10-14 Yossi Tuval Sinus-Engaging Valve Fixation Member
US8876894B2 (en) 2006-09-19 2014-11-04 Medtronic Ventor Technologies Ltd. Leaflet-sensitive valve fixation member
US20080071368A1 (en) * 2006-09-19 2008-03-20 Yosi Tuval Sinus-engaging valve fixation member
US20100137979A1 (en) * 2006-09-19 2010-06-03 Yosi Tuval Sinus-engaging Valve Fixation Member
US8414643B2 (en) 2006-09-19 2013-04-09 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US8834564B2 (en) 2006-09-19 2014-09-16 Medtronic, Inc. Sinus-engaging valve fixation member
US8348996B2 (en) 2006-09-19 2013-01-08 Medtronic Ventor Technologies Ltd. Valve prosthesis implantation techniques
US10543077B2 (en) 2006-09-19 2020-01-28 Medtronic, Inc. Sinus-engaging valve fixation member
US8876895B2 (en) 2006-09-19 2014-11-04 Medtronic Ventor Technologies Ltd. Valve fixation member having engagement arms
US20080071362A1 (en) * 2006-09-19 2008-03-20 Yosi Tuval Valve prosthesis implantation techniques
US8784478B2 (en) 2006-10-16 2014-07-22 Medtronic Corevalve, Inc. Transapical delivery system with ventruculo-arterial overlfow bypass
US8747459B2 (en) 2006-12-06 2014-06-10 Medtronic Corevalve Llc System and method for transapical delivery of an annulus anchored self-expanding valve
US20080140189A1 (en) * 2006-12-06 2008-06-12 Corevalve, Inc. System and method for transapical delivery of an annulus anchored self-expanding valve
US9295550B2 (en) 2006-12-06 2016-03-29 Medtronic CV Luxembourg S.a.r.l. Methods for delivering a self-expanding valve
US20080262593A1 (en) * 2007-02-15 2008-10-23 Ryan Timothy R Multi-layered stents and methods of implanting
US7871436B2 (en) 2007-02-16 2011-01-18 Medtronic, Inc. Replacement prosthetic heart valves and methods of implantation
US9504568B2 (en) 2007-02-16 2016-11-29 Medtronic, Inc. Replacement prosthetic heart valves and methods of implantation
US20080243246A1 (en) * 2007-02-16 2008-10-02 Ryan Timothy R Replacement prosthetic heart valves and methods of implantation
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US9237886B2 (en) 2007-04-20 2016-01-19 Medtronic, Inc. Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US9585754B2 (en) 2007-04-20 2017-03-07 Medtronic, Inc. Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US10188516B2 (en) 2007-08-20 2019-01-29 Medtronic Ventor Technologies Ltd. Stent loading tool and method for use thereof
US20090088833A1 (en) * 2007-09-28 2009-04-02 Maximiliano Soetermans Double wall stent with retrieval member
US10856970B2 (en) 2007-10-10 2020-12-08 Medtronic Ventor Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US10966823B2 (en) 2007-10-12 2021-04-06 Sorin Group Italia S.R.L. Expandable valve prosthesis with sealing mechanism
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US20090171451A1 (en) * 2007-12-27 2009-07-02 Cook Incorporated Implantable device having composite weave
US10016274B2 (en) 2008-01-24 2018-07-10 Medtronic, Inc. Stent for prosthetic heart valves
US8685077B2 (en) 2008-01-24 2014-04-01 Medtronics, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US11786367B2 (en) 2008-01-24 2023-10-17 Medtronic, Inc. Stents for prosthetic heart valves
US11607311B2 (en) 2008-01-24 2023-03-21 Medtronic, Inc. Stents for prosthetic heart valves
US9925079B2 (en) 2008-01-24 2018-03-27 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US8673000B2 (en) 2008-01-24 2014-03-18 Medtronic, Inc. Stents for prosthetic heart valves
US20090192585A1 (en) * 2008-01-24 2009-07-30 Medtronic, Inc. Delivery Systems and Methods of Implantation for Prosthetic Heart Valves
US20090198316A1 (en) * 2008-01-24 2009-08-06 Medtronic, Inc. Delivery Systems and Methods of Implantation for Prosthetic Heart Valves
US20090287290A1 (en) * 2008-01-24 2009-11-19 Medtronic, Inc. Delivery Systems and Methods of Implantation for Prosthetic Heart Valves
US8628566B2 (en) 2008-01-24 2014-01-14 Medtronic, Inc. Stents for prosthetic heart valves
US20090192586A1 (en) * 2008-01-24 2009-07-30 Medtronic, Inc. Delivery Systems for Prosthetic Heart Valves
US9333100B2 (en) 2008-01-24 2016-05-10 Medtronic, Inc. Stents for prosthetic heart valves
US9339382B2 (en) 2008-01-24 2016-05-17 Medtronic, Inc. Stents for prosthetic heart valves
US20090292350A1 (en) * 2008-01-24 2009-11-26 Medtronic, Inc. Stents for Prosthetic Heart Valves
US9393115B2 (en) 2008-01-24 2016-07-19 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US20090254165A1 (en) * 2008-01-24 2009-10-08 Medtronic,Inc. Delivery Systems and Methods of Implantation for Prosthetic Heart Valves
US11284999B2 (en) 2008-01-24 2022-03-29 Medtronic, Inc. Stents for prosthetic heart valves
US7972378B2 (en) 2008-01-24 2011-07-05 Medtronic, Inc. Stents for prosthetic heart valves
US11259919B2 (en) 2008-01-24 2022-03-01 Medtronic, Inc. Stents for prosthetic heart valves
US20110224780A1 (en) * 2008-01-24 2011-09-15 Charles Tabor Stents for prosthetic heart valves
US11083573B2 (en) 2008-01-24 2021-08-10 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US10639182B2 (en) 2008-01-24 2020-05-05 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US10820993B2 (en) 2008-01-24 2020-11-03 Medtronic, Inc. Stents for prosthetic heart valves
US10758343B2 (en) 2008-01-24 2020-09-01 Medtronic, Inc. Stent for prosthetic heart valves
US9149358B2 (en) 2008-01-24 2015-10-06 Medtronic, Inc. Delivery systems for prosthetic heart valves
US9089422B2 (en) 2008-01-24 2015-07-28 Medtronic, Inc. Markers for prosthetic heart valves
US8157852B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US10646335B2 (en) 2008-01-24 2020-05-12 Medtronic, Inc. Stents for prosthetic heart valves
US8157853B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11154398B2 (en) 2008-02-26 2021-10-26 JenaValve Technology. Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US8613765B2 (en) 2008-02-28 2013-12-24 Medtronic, Inc. Prosthetic heart valve systems
US8961593B2 (en) 2008-02-28 2015-02-24 Medtronic, Inc. Prosthetic heart valve systems
US20090264989A1 (en) * 2008-02-28 2009-10-22 Philipp Bonhoeffer Prosthetic heart valve systems
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US11278408B2 (en) 2008-03-18 2022-03-22 Medtronic Venter Technologies, Ltd. Valve suturing and implantation procedures
US11602430B2 (en) 2008-03-18 2023-03-14 Medtronic Ventor Technologies Ltd. Valve suturing and implantation procedures
US9592120B2 (en) 2008-03-18 2017-03-14 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US10856979B2 (en) 2008-03-18 2020-12-08 Medtronic Ventor Technologies Ltd. Valve suturing and implantation procedures
US10245142B2 (en) 2008-04-08 2019-04-02 Medtronic, Inc. Multiple orifice implantable heart valve and methods of implantation
US20090259292A1 (en) * 2008-04-08 2009-10-15 Medtronic, Inc. Multiple Orifice Implantable Heart Valve and Methods of Implantation
US8430927B2 (en) 2008-04-08 2013-04-30 Medtronic, Inc. Multiple orifice implantable heart valve and methods of implantation
US20100023120A1 (en) * 2008-04-23 2010-01-28 Holecek Arin N Tissue attachment devices and methods for prosthetic heart valves
US8696743B2 (en) 2008-04-23 2014-04-15 Medtronic, Inc. Tissue attachment devices and methods for prosthetic heart valves
US8511244B2 (en) 2008-04-23 2013-08-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US8312825B2 (en) 2008-04-23 2012-11-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US20100018447A1 (en) * 2008-04-23 2010-01-28 Holecek Arin N Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
US11026786B2 (en) 2008-09-15 2021-06-08 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US8998981B2 (en) 2008-09-15 2015-04-07 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US20100121436A1 (en) * 2008-09-15 2010-05-13 Yossi Tuval Prosthetic Heart Valve Having Identifiers for Aiding in Radiographic Positioning
US9943407B2 (en) 2008-09-15 2018-04-17 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US10806570B2 (en) 2008-09-15 2020-10-20 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US20100069852A1 (en) * 2008-09-17 2010-03-18 Gregory Scott Kelley Delivery system for deployment of medical devices
US10321997B2 (en) 2008-09-17 2019-06-18 Medtronic CV Luxembourg S.a.r.l. Delivery system for deployment of medical devices
US8721714B2 (en) 2008-09-17 2014-05-13 Medtronic Corevalve Llc Delivery system for deployment of medical devices
US9532873B2 (en) 2008-09-17 2017-01-03 Medtronic CV Luxembourg S.a.r.l. Methods for deployment of medical devices
US11166815B2 (en) 2008-09-17 2021-11-09 Medtronic CV Luxembourg S.a.r.l Delivery system for deployment of medical devices
US8137398B2 (en) 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
US20100094411A1 (en) * 2008-10-13 2010-04-15 Vector Technologies, Ltd. Prosthetic valve having tapered tip when compressed for delivery
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US10098733B2 (en) 2008-12-23 2018-10-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US8512397B2 (en) 2009-04-27 2013-08-20 Sorin Group Italia S.R.L. Prosthetic vascular conduit
US20110082539A1 (en) * 2009-10-05 2011-04-07 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US9226826B2 (en) 2010-02-24 2016-01-05 Medtronic, Inc. Transcatheter valve structure and methods for valve delivery
US20110208283A1 (en) * 2010-02-24 2011-08-25 Rust Matthew J Transcatheter valve structure and methods for valve delivery
US8652204B2 (en) 2010-04-01 2014-02-18 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US10716665B2 (en) 2010-04-01 2020-07-21 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US11833041B2 (en) 2010-04-01 2023-12-05 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US9925044B2 (en) 2010-04-01 2018-03-27 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US11554010B2 (en) 2010-04-01 2023-01-17 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US9248017B2 (en) 2010-05-21 2016-02-02 Sorin Group Italia S.R.L. Support device for valve prostheses and corresponding kit
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US11786368B2 (en) 2010-09-01 2023-10-17 Medtronic Vascular Galway Prosthetic valve support structure
US10835376B2 (en) 2010-09-01 2020-11-17 Medtronic Vascular Galway Prosthetic valve support structure
US9918833B2 (en) 2010-09-01 2018-03-20 Medtronic Vascular Galway Prosthetic valve support structure
US9289289B2 (en) 2011-02-14 2016-03-22 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9161836B2 (en) 2011-02-14 2015-10-20 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US8685084B2 (en) 2011-12-29 2014-04-01 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US9138314B2 (en) 2011-12-29 2015-09-22 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US9629718B2 (en) 2013-05-03 2017-04-25 Medtronic, Inc. Valve delivery tool
US10568739B2 (en) 2013-05-03 2020-02-25 Medtronic, Inc. Valve delivery tool
US11793637B2 (en) 2013-05-03 2023-10-24 Medtronic, Inc. Valve delivery tool
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
US11951007B2 (en) 2020-04-13 2024-04-09 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves

Also Published As

Publication number Publication date
US6331191B1 (en) 2001-12-18
EP1625833A3 (en) 2010-09-22
WO1999026559A1 (en) 1999-06-03
EP2314256A1 (en) 2011-04-27
US20040220664A1 (en) 2004-11-04
EP1625833A2 (en) 2006-02-15
EP1032328A1 (en) 2000-09-06

Similar Documents

Publication Publication Date Title
US6331191B1 (en) Layered endovascular graft
US10682222B2 (en) Modular vascular graft for low profile percutaneous delivery
US11065097B2 (en) Advanced kink-resistant stent graft
US6132457A (en) Endovascular graft having longitudinally displaceable sections
US8226701B2 (en) Stent and delivery system for deployment thereof
US6355060B1 (en) Apparatus and method for deployment release of intraluminal prostheses
JP3280034B2 (en) Stent graft against kink
US5749918A (en) Intraluminal graft and method for inserting the same
EP1061985B1 (en) Delivery system for deployment and endovascular assembly of multi-stage stent graft
EP0880948B1 (en) Stent and stent-graft for treating branched vessels
US20060224232A1 (en) Hybrid modular endovascular graft
JPH0852165A (en) Device and method for arrangement of transplanting piece in cavity
US20220071785A1 (en) Tandem modular endograft
WO2004103451A1 (en) Temporarily indwelled stent and stent graft
US20090230167A1 (en) Endostapler Biasing Mechanism
US20090259295A1 (en) Method of Delivering Graft Material Without the Use of a Stent
US20100179565A1 (en) Rail for Delivering an Endovascular Stapler

Legal Events

Date Code Title Description
AS Assignment

Owner name: TRIVASCULAR, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CHOBOTOV, MICHAEL V.;REEL/FRAME:012888/0965

Effective date: 20011204

STCB Information on status: application discontinuation

Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION

AS Assignment

Owner name: DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT, NEW YORK

Free format text: SECURITY INTEREST;ASSIGNORS:ENDOLOGIX, INC.;NELLIX, INC.;TRIVASCULAR, INC.;REEL/FRAME:046772/0933

Effective date: 20180809

Owner name: DEERFIELD ELGX REVOLVER, LLC, AS AGENT, NEW YORK

Free format text: SECURITY INTEREST;ASSIGNORS:ENDOLOGIX, INC.;NELLIX, INC.;TRIVASCULAR, INC.;REEL/FRAME:046762/0169

Effective date: 20180809

Owner name: DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT,

Free format text: SECURITY INTEREST;ASSIGNORS:ENDOLOGIX, INC.;NELLIX, INC.;TRIVASCULAR, INC.;REEL/FRAME:046772/0933

Effective date: 20180809

AS Assignment

Owner name: ENDOLOGIX LLC, CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:ENDOLOGIX, INC.;REEL/FRAME:053971/0135

Effective date: 20201001

Owner name: DEERFIELD PRIVATE DESIGN FUND IV, L.P., NEW YORK

Free format text: SECURITY INTEREST;ASSIGNORS:ENDOLOGIX LLC (F/K/A ENDOLOGIX, INC.);NELLIX, INC.;TRIVASCULAR TECHNOLOGIES, INC.;AND OTHERS;REEL/FRAME:053971/0052

Effective date: 20201001